Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? Meeting Abstract


Authors: Abou-Alfa, G. K.; Amadori, D.; Santoro, A.; Figer, A.; De Greve, J.; Lathia, C.; Voliotis, D.; Anderson, S.; Moscovici, M.; Ricci, S.
Abstract Title: Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 217s
Language: English
ACCESSION: WOS:000208457401409
DOI: 10.1200/jco.2008.26.15_suppl.4518
PROVIDER: Clarivate Analytics Web of Science
PROVIDER: wos
Notes: Meeting Abstract: 4518 -- Source: Wos
Altmetric Score
MSK Authors
  1. Ghassan Abou-Alfa
    229 Abou-Alfa